Summary
- Current Price
- As of today, MRKR price is $1.17, unchanged in the most recent trading session on
- Current Price All-Time High
- MRKR price is currently -100.00% below its historical high of $6,120,000.00 set on
- Market Cap
- MRKR current market cap is $20M, up +81.48% over the past 365 days
- Revenue
- MRKR current annual revenue is $3.55M, down -46.19% year-over-year
- Next Earnings
- As of today, the next earnings release for MRKR has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Marker Therapeutics, Inc. |
| Ticker | NASDAQ: MRKR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | markertherapeutics.com |
| Employees | 5 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.17 | ||
| Price, 1D Change | 0.00% | |
| $20M | ||
| - | ||
| - | ||
| 1.06 | ||
| $3.55M | ||
| Revenue, 1Y Change | -46.19% | |
| -$0.79 | ||
| EPS, 1Y Change | +33.51% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | TPIV | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.79 | ||
| EPS Estimate | -$0.57 | N/A |
| EPS Est. Change | +28.89% | N/A |
| $3.55M | ||
| Revenue Estimate | $4.24M | N/A |
| Revenue Est. Change | +19.60% | N/A |
| $1.17 | ||
| Price Target | $8.00 | - |
| Price Tgt. Change | +583.76% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.97 | -$1.20 | -23.20% | |
| -$0.94 | -$0.79 | +15.03% | |
| -$0.57 | N/A | +28.89% | |
| -$0.53 | N/A | +33.29% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $8.32M | $6.59M | -20.79% | |
| $3.10M | $3.55M | +14.53% | |
| $4.24M | N/A | +19.60% | |
| $20.19M | N/A | +469.14% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +23.16% | ||
| -78.17% | ||
| +81.48% | ||
| -58.64% | ||
| -46.19% | ||
| +0.94% | ||
| +33.51% | ||
| +77.83% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.17 | ||
| $1.44 | ||
| $1.28 | ||
| $1.39 | ||
| $1.28 | ||
| -$0.03 | ||
| 1.06 | ||
| $0.11 | ||
| 42.98 | ||
| 65.31% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $3.55M | ||
| -$0.79 | ||
| $0.00 | ||
| 0.00% | ||
| -$12.44M | ||
| -350.67% | ||
| -$12.16M | ||
| -342.96% | ||
| -$12.44M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 8.39 | ||
| 8.39 | ||
| - | ||
| - | ||
| -29.47 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 8.35 | ||
| 1.60 | ||
| -0.71 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $16.80M | ||
| $17.04M | ||
| $19.07M | ||
| $19.07M | ||
| $2.27M | ||
| $2.27M | ||
| $0.00 | ||
| $0.00 | ||
| $793.70K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $15.71M | ||
| $12.44M | ||
| - | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| -$15.20K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$12.01M | ||
| $0.00 | ||
| $9.86M | ||
| $0.00 | ||
| -$12.01M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | ||
| WBB Securities | → | |
| Canaccord Genuity | ||
| Ladenburg Thalmann | ||
| Roth Capital | → | |
| Piper Sandler | ||
| Cantor Fitzgerald | ||
| Cantor Fitzgerald | ||
| Piper Sandler | → | |
| Piper Jaffray |
Analyst sentiment
Institutional ownership
Screeners with MRKR
FAQ
- What is the ticker symbol for Marker Therapeutics, Inc.?
- The ticker symbol for Marker Therapeutics, Inc. is NASDAQ:MRKR
- Does Marker Therapeutics, Inc. pay dividends?
- No, Marker Therapeutics, Inc. does not pay dividends
- What sector is Marker Therapeutics, Inc. in?
- Marker Therapeutics, Inc. is in the Healthcare sector
- What industry is Marker Therapeutics, Inc. in?
- Marker Therapeutics, Inc. is in the Biotechnology industry
- What country is Marker Therapeutics, Inc. based in?
- Marker Therapeutics, Inc. is headquartered in United States
- When did Marker Therapeutics, Inc. go public?
- Marker Therapeutics, Inc. initial public offering (IPO) was on July 16, 2002
- Is Marker Therapeutics, Inc. in the S&P 500?
- No, Marker Therapeutics, Inc. is not included in the S&P 500 index
- Is Marker Therapeutics, Inc. in the NASDAQ 100?
- No, Marker Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Marker Therapeutics, Inc. in the Dow Jones?
- No, Marker Therapeutics, Inc. is not included in the Dow Jones index
- When was Marker Therapeutics, Inc. last earnings report?
- Marker Therapeutics, Inc.'s most recent earnings report was on November 14, 2025
- When does Marker Therapeutics, Inc. report earnings?
- The date for Marker Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- MRKR Official Website markertherapeutics.com
- MRKR Profile on Yahoo Finance finance.yahoo.com/quote/MRKR
- MRKR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrkr